These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 10955155

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
    Feagan BG, Sandborn WJ.
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S9-15. PubMed ID: 12478239
    [Abstract] [Full Text] [Related]

  • 3. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
    Mantzaris GJ, Petraki K, Sfakianakis M, Archavlis E, Christidou A, Chadio-Iordanides H, Triadaphyllou G.
    Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Paradigmatic shift in drug treatment of Crohn disease].
    Munck LK.
    Ugeskr Laeger; 2005 Aug 15; 167(33):3013. PubMed ID: 16109239
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [New research results give hope. Causal therapy of Crohn disease in sight].
    MMW Fortschr Med; 2004 Apr 01; 146(14):42-3. PubMed ID: 15344754
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Budesonide: its role in Crohn's disease therapy.
    Coleman CI, Reddy P, White CM.
    Conn Med; 2002 Sep 01; 66(9):523-6. PubMed ID: 12369546
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Budesonide led to a greater remission rate and fewer severe adverse events than did mesalamine in Crohn's disease.
    Rutgeerts P.
    Gut; 1999 Jul 01; 45(1):13-4. PubMed ID: 10498451
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Budesonide for Crohn's disease.
    Seow CH, Benchimol EI, Steinhart AH, Griffiths AM, Otley AR.
    Expert Opin Drug Metab Toxicol; 2009 Aug 01; 5(8):971-9. PubMed ID: 19611401
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Drug therapy of Crohn disease].
    Niemelä S.
    Duodecim; 2001 Aug 01; 117(8):807-14. PubMed ID: 12116446
    [No Abstract] [Full Text] [Related]

  • 18. Budesonide modified-release capsules.
    Baker DE.
    Rev Gastroenterol Disord; 2001 Aug 01; 1(3):147-55. PubMed ID: 12120182
    [Abstract] [Full Text] [Related]

  • 19. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
    Feagan BG.
    Eur J Surg; 1998 Dec 01; 164(12):903-9. PubMed ID: 10029385
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.